Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 261 - 280 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »
Reset ↻

Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Iovance Biotherapeutics, Inc.

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Rhythm Pharmaceuticals, Inc.

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Intra-Cellular Therapies, Inc.

FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Onco

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: FibroGen, Inc.

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: ClearPoint Neuro, Inc.

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Cidara Therapeutics, Inc.

Erasca Announces Three Presentations at the 2024 ASCO Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Erasca, Inc.

Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Venus Concept Inc.

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Black Diamond Therapeutics Inc.

23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: 23andMe, Inc.

Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Corbus Pharmaceuticals Holdings, Inc.

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Predictive Oncology Inc.

NextCure to Present Phase 1b Data of NC410 in Combination with Pembrolizumab at ASCO 2024

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: NextCure, Inc

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Sensei Biotherapeutics, Inc.

QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Qiagen NV

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Corcept Therapeutics Incorporated

TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: TScan Therapeutics, Inc.

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Supernus Pharmaceuticals, Inc.

Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Spectral AI, Inc.

Entourage Health to Report Fiscal Year 2023 Financial Results

Read more ››

By: GlobeNewswire - 24 Apr 2024

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

to the top ↑